Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
sortieren
Medicine and Dentistry
Liver Cirrhosis
96%
Bleeding
83%
Artificial Intelligence
68%
Adverse Event
63%
Colonoscopy
60%
Endoscopic Retrograde Cholangiopancreatography
57%
Hepatocellular Carcinoma
55%
Prevalence
55%
Prospective Study
53%
Systematic Review
51%
Odds Ratio
49%
Diseases
45%
Hepatology
45%
Inflammatory Bowel Disease
45%
Biopsy Technique
45%
Endoscopy
41%
Ribavirin
38%
Cohort Analysis
37%
Geriatrics
36%
Chronic Liver Disease
36%
Pancreatitis
36%
Long-Term Care
34%
Venous Thromboembolism
34%
COVID-19
34%
Upper Gastrointestinal Bleeding
34%
Health Care
34%
Eosinophilic Esophagitis
34%
Lenvatinib
34%
Acute Kidney Injury
34%
Endoscopic Ultrasound
34%
Quality of Life
32%
Adenoma
32%
Cancer
31%
Portal Hypertension
30%
Polyp
29%
Fine-Needle Aspiration
28%
Liver Transplantation
28%
Fibrosis
27%
Ulcer
27%
Patient with Inflammatory Bowel Disease
25%
Hepatitis C
25%
Chronic Pancreatitis
25%
Gastrointestinal Endoscopy
24%
Liver Disease
23%
Pancreatic Duct
22%
Recurrent Disease
22%
Acute Pancreatitis
22%
Puncture
22%
Magnetic Resonance Imaging
22%
Major Bleeding
22%
Antiviral Therapy
21%
Anticoagulation
21%
Meta-Analysis
21%
Decompensated Liver Cirrhosis
20%
Rituximab
20%
Placebo
20%
Arthralgia
20%
Proton-Pump Inhibitor
20%
Gastroenterology
20%
Cross Sectional Study
20%
Colorectal Carcinoma
19%
Colon
19%
Charlson Comorbidity Index
19%
Virus RNA
19%
Platelet
19%
Metabolic Dysfunction-Associated Steatotic Liver Disease
19%
Retrospective Study
18%
Necrosis
18%
Interferon
18%
Chronic Hepatitis C
17%
Viral Clearance
17%
Von Willebrand Factor
17%
Complementary and Alternative Medicine
17%
Stomach Tumor
17%
Computer Assisted Tomography
17%
Atrial Fibrillation
17%
Upper Respiratory Tract Infection
17%
Granulomatosis with Polyangiitis
17%
Arthritis
17%
Fingertip
17%
Mastoiditis
17%
Zenker's Diverticulum
17%
Cohort Effect
17%
Pancreas Tumor
17%
Hepatitis Delta Virus
17%
Diagnostic Delay
17%
Esophageal Stent
17%
Cardiovascular Disease
17%
Cystectomy
17%
Cholecystectomy
17%
Nonalcoholic Fatty Liver
17%
Etanercept
17%
Cystostomy
17%
Abatacept
17%
Polyarthritis
17%
Lupus Erythematosus Panniculitis
17%
Colorectal Cancer Screening
17%
Network Meta-Analysis
17%
Episodic Migraine
17%
Triptan Derivative
17%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
100%
Prevalence
70%
Liver Cell Carcinoma
58%
Hepatitis C Virus
52%
Inflammatory Bowel Disease
51%
Chronic Hepatitis C
45%
Liver Disease
43%
Ribavirin
42%
Bleeding
39%
Viral Clearance
36%
Virus RNA
36%
Adverse Event
36%
Diseases
35%
Interferon
35%
Nonalcoholic Fatty Liver
34%
Venous Thromboembolism
34%
Lenvatinib
34%
Ulcerative Colitis
34%
Colorectal Carcinoma
34%
Hepatitis C
29%
Antiviral Drug
28%
Fibrosis
27%
Pharmacokinetics
25%
Pancreatitis
22%
Cohort Study
21%
Decompensated Liver Cirrhosis
20%
Observational Study
20%
Placebo
20%
Antiviral Therapy
19%
Infection
19%
SARS Coronavirus
18%
Crohn's Disease
17%
Metformin
17%
Von Willebrand Factor
17%
Insulin Dependent Diabetes Mellitus
17%
Microdosing
17%
Ciprofloxacin
17%
Retrospective Study
17%
Bone Lesion
17%
Autoimmune Thyroiditis
17%
Antibiotics
17%
Dysglycemia
17%
Proton Pump Inhibitor
17%
Pibrentasvir
17%
Reducing Agent
17%
Glecaprevir
17%
Abatacept
17%
Acute Kidney Failure
17%
Cardiovascular Disease
17%
Felty's Syndrome
17%
Triptan Derivative
17%
Episodic Migraine
17%
Neopterin
17%
Selenoprotein P
17%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
17%
Recurrent Disease
17%
Atezolizumab
17%
Ferritin
17%
Paracetamol
17%
Bevacizumab
17%
Inflammation
17%
Pandemic
17%
Etanercept
17%
Adalimumab
17%
Hepatitis Delta Virus
17%
Cancer Mortality
17%
Peginterferon Alpha
17%
Alpha2a Interferon
17%
Antivirus Agent
14%
Fatty Liver
14%
Mortality Rate
13%
Non-Steroidal Anti-Inflammatory Drug
13%
Adenoma
13%
Coronary Artery Calcification
12%
Sofosbuvir
11%
Portal Hypertension
10%
Replacement Therapy
10%
Virus Infection
9%
Cholestasis
8%
Ombitasvir
8%
Paritaprevir
8%
Ritonavir
8%
Dasabuvir
8%
Rheumatoid Factor
8%
Tocilizumab
8%
Transferrin
8%
Interferon Type III
8%
Glucocorticoid
8%
Overall Survival
8%
Disease Exacerbation
8%
Biological Marker
8%
Biological Product
8%
Cross-Validation
8%
Atherosclerotic Plaque
8%
Opiate Agonist
8%
Viremia
8%
Progression Free Survival
8%
Alanine Aminotransferase
7%
Varicosis
7%
Ascites
7%